JP Morgan Chase’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5
Closed -$32 7355
2024
Q1
$32 Buy
5
+1
+25% +$8 ﹤0.01% 7104
2023
Q4
$35 Buy
4
+2
+100% +$15 ﹤0.01% 7253
2023
Q3
$16 Buy
+2
New +$20 ﹤0.01% 7213
2023
Q2
Sell
-250
Closed -$3.74K 6929
2023
Q1
$3.74K Buy
+250
New +$5.39K ﹤0.01% 6327
2020
Q4
Sell
-1
Closed 5638
2020
Q3
$0 Hold
1
﹤0.01% 5481
2020
Q2
$0 Buy
+1
New +$56 ﹤0.01% 5377

Other funds holding BMRA

JP Morgan Chase's BMRA Position: Q2 2024 in Review

JP Morgan Chase sold out of Biomerica (BMRA) in Q2 2024, closing a stake of 5 shares — an estimated $32 sold.

JP Morgan Chase first reported a position in BMRA in Q2 2020 and held it in 6 quarters. The position peaked at $3.74K in Q1 2023. 35 funds tracked by Wall St. Rank hold BMRA as of Q2 2024.

  • JP Morgan Chase reported no remaining Biomerica position as of Q2 2024 after selling out during the quarter.
  • JP Morgan Chase sold 5 Biomerica shares in Q2 2024, an estimated $32.
  • JP Morgan Chase first reported a position in Biomerica in Q2 2020 and held it in 6 quarters.
  • JP Morgan Chase's Biomerica position peaked at $3.74K in Q1 2023.
  • 35 funds tracked by Wall St. Rank held Biomerica as of Q2 2024.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.